Respiratory syncytial virus infection and chronic respiratory morbidity – is there a functional or genetic predisposition?

Authors

  • Simon B Drysdale,

    1. Division of Asthma, Allergy and Lung Biology, the MRC and Asthma UK Centre in Allergic Mechanisms of Asthma, King’s College London, London, UK
    Search for more papers by this author
  • Anthony D Milner,

    1. Division of Asthma, Allergy and Lung Biology, the MRC and Asthma UK Centre in Allergic Mechanisms of Asthma, King’s College London, London, UK
    Search for more papers by this author
  • Anne Greenough

    1. Division of Asthma, Allergy and Lung Biology, the MRC and Asthma UK Centre in Allergic Mechanisms of Asthma, King’s College London, London, UK
    Search for more papers by this author

A Greenough, Neonatal Intensive Care Centre, 4th Floor Golden Jubilee Wing, King’s College Hospital, Denmark Hill, London SE5 9RS, UK. Tel: +44 20 3299 3037 | Fax: +44 20 3299 8284 | Email: anne.greenough@kcl.ac.uk

Abstract

A systematic literature review has been undertaken. Respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) in infancy is associated with chronic respiratory morbidity. Premorbid abnormal lung function may predispose to RVS LRTI in prematurely born infants.

Conclusion:  Single-nucleotide polymorphisms in genes coding for IL-8, IL-19, IL-20, IL-13 mannose-binding lectin, IFNG and a RANTES polymorphism have been associated with subsequent wheeze following RSV LRTI in term-born infants.

Ancillary